Mieloproliferatív neopláziák: vizsgálatok itt: Malajzia
4 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
- Where
- George Town, Johor Bahru, Kota Kinabalu, Kuala Selangor, Kuching
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07357727 · EU 2025-523555-66-00 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- George Town, Johor Bahru, Kuala Selangor
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 3. fázisNot yet taking people in MalajziaA Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
- Where
- Ampang, George Town, Kota Kinabalu, Kuala Lumpur
- Életkor
- 18 év and over
- People
- 324 worldwide
- Run by
- Takeda
See details and how to joinNCT07623161 · EU 2026-525660-17-00 - 3. fázisTaking peopleA Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Where
- Alor Star, Ipoh, Johor Bahru, Kota Kinabalu, Kuala Lumpur, Kuching
- Életkor
- 18 év and over
- People
- 665 worldwide
- Run by
- Celgene
See details and how to joinNCT04064060